3 Stocks I Saw on T...
Health Care: Drugs
Flamel Technologies (FLML: NASDAQ)
$4.43 0.09 | 1.98%
06/04/12 - 12:14 PM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -8.77M | -8.98M | -11.44M | -12.08M |
| Operating Gains/Losses | -3.28M | -1.03M | -2.68M | -1.69M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -4.40M | 1.57M | 2.81M | -3.89M |
| (Increase) Decrease in Inventories | -917.00K | 152.00K | 909.00K | -171.00K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -825.00K | -450.00K | 32.00K | -258.00K |
| (Decrease) Increase In Other Current Liabilities | -92.00K | -1.54M | 2.70M | -1.36M |
| (Increase) Decrease In Other Working Capital | 985.00K | -4.02M | 6.16M | -4.09M |
| Other Non-Cash Items | 2.78M | 3.17M | 5.50M | 8.29M |
| Net Cash From Continuing Operations | -10.32M | -5.46M | 8.20M | -7.51M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -10.32M | -5.46M | 8.20M | -7.51M |
| Sale of Property, Plant & Equipment | 185.00K | 131.00K | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 26.38M | 83.13M | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.90M | -3.60M | -1.77M | -3.52M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -25.02M | -73.63M | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -351.00K | 6.03M | -24.26M | 911.00K |
| Issuance of Debt | 7.86M | 436.00K | 2.19M | 8.61M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 296.00K | 704.00K | 291.00K | 540.00K |
| Repayment of Long-Term Debt | -2.01M | -35.00K | -67.00K | -272.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | -1.88M | -4.00M | 0.00 |
| Net Cash From Financing Activities | 6.14M | -774.00K | -1.58M | 8.88M |
| Effect of Exchange Rate Changes | -199.00K | -329.00K | -654.00K | -1.58M |
| Net Change in Cash & Cash Equivalents | -4.73M | -532.00K | -18.30M | 708.00K |
Portfolios with FLML
- Portfolio NameUser Type
- Contributor10 Top-Rated Buys Under $10
- Contributor10 Stocks Under $10 With Up...
- Usergreentree
- UserSalvelinus Fontinalis
- UserBVF Inc.
- UserBoondoggler22 Portfolio 1
- UserFATZ 1
- Userndecas Portfolio 1
- UserRooster Fund
- UserLGS-1 Portfolio 1
Latest FLML Headlines from TheStreet
- Flamel Technologies' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.07.12 | 11:05 am
- Flamel Technologies' CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.15.12 | 01:03 pm
- Flamel Technologies's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.03.11 | 11:11 am
- Flamel Technologies CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.26.11 | 01:07 pm
- Flamel Technologies CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.09.11 | 10:05 am
- Flamel Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript 03.04.11 | 12:03 pm
- Flamel Technologies CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.05.10 | 11:11 pm
- Flamel Technologies SA Q2 2010 Earnings Call Transcript 07.29.10 | 02:07 pm
- Thursday's Health Winners & Losers 12.20.07 | 02:12 pm
- Wednesday's Health Winners & Losers 12.05.07 | 04:12 am
Press Releases for FLML
- Flamel Technologies Announces First Quarter 2012 Results - Business Wire 05.07.12 | 07:05 am
- Flamel Technologies Announces Fourth Quarter And Year-End 2011 Results - Business Wire 03.14.12 | 06:03 pm
- Flamel Technologies Announces Acquisition Of Éclat Pharmaceuticals - Business Wire 03.14.12 | 06:03 pm
- Flamel Technologies Announces Profitable Third Quarter Results - Business Wire 11.02.11 | 04:11 pm
- Flamel Technologies Announces Multi-Year Supply Agreement With GlaxoSmithKline For Coreg CR™ Microparticles - Business Wire 10.18.11 | 08:10 am
- Eagle Pharmaceuticals And Flamel Technologies Announce Eagle To License Medusa Technology For Extended-Release Of Tigecycline - Business Wire 10.13.11 | 09:10 am
- Flamel Technologies And Digna Biotech Announce Multiple Product Development Agreement - Business Wire 06.27.11 | 08:06 am
- Flamel Technologies Announces Results Of Annual Meeting - Business Wire 06.24.11 | 08:06 am
- Flamel Technologies Announces Nomination Of Ambassador Craig Stapleton, Dr. Catherine Bréchignac And Mr. Guillaume Cerutti For Election To The Board Of Directors - Business Wire 05.31.11 | 08:05 am
- Flamel Technologies Announces Expanded Partnership Relations; First Quarter Results - Business Wire 05.09.11 | 06:05 am
Partner Headlines for FLML
- 16 Micro-Cap Stocks Being Targeted By Short Sellers - Seeking Alpha 10.26.11 | 09:10 am
- Investors roll positions on options expiration day - Reuters 08.20.10 | 03:08 pm
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.04.10 | 09:08 am
